EP1208843A1 — Soft capsules
Assigned to Chugai Pharmaceutical Co Ltd · Expires 2002-05-29 · 24y expired
What this patent protects
An object of the present invention is to provide soft capsule formulations of active vitamins D 3 well-suited to practical production with easy discrimination of active ingredient levels, in which stability of the active vitamins D 3 to light and heat is ensured, and which mate…
USPTO Abstract
An object of the present invention is to provide soft capsule formulations of active vitamins D 3 well-suited to practical production with easy discrimination of active ingredient levels, in which stability of the active vitamins D 3 to light and heat is ensured, and which material is highly safe to the human body. According to the present invention, soft capsule formulations of active vitamins D 3 can be obtained wherein the capsule shell contains a white pigment and yellow iron oxide and/or red iron oxide, or titanium oxide and caramel, or yellow iron oxide.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.